Several studies demonstrated that Src, a proto-oncogenic nonreceptor tyrosine kinase, activated STAT3, which resulted in the stimulation of tumor growth and the pathway plays important roles in tumorigenicity 11-13. The gene discussed is STAT3; the disease is neoplasm.